Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts.

[1]  Tae-Wook Chung,et al.  Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. , 2002, Archives of biochemistry and biophysics.

[2]  Jui-Sheng Sun,et al.  The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. , 2002, Biomaterials.

[3]  Young-Choon Lee,et al.  Inhibitory effect of a Korean traditional medicine, Honghwain-Jahage (water extracts of Carthamus tinctorius L. seed and Hominis placenta) on interleukin-1-mediated bone resorption. , 2002, Journal of ethnopharmacology.

[4]  Y. L. Lin,et al.  Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. , 2001, Journal of the Formosan Medical Association = Taiwan yi zhi.

[5]  I. James,et al.  Biosynthesis and processing of cathepsin K in cultured human osteoclasts. , 2001, Bone.

[6]  J. Falgueyret,et al.  Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. , 2001, Journal of medicinal chemistry.

[7]  Juei-Tang Cheng,et al.  Review: Drug Therapy in Chinese Traditional Medicine , 2000, Journal of clinical pharmacology.

[8]  R Yuan,et al.  Traditional Chinese medicine: an approach to scientific proof and clinical validation. , 2000, Pharmacology & therapeutics.

[9]  M. Lark,et al.  Development and Characterization of a Human In Vitro Resorption Assay: Demonstration of Utility Using Novel Antiresorptive Agents , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Yuqiong Liang,et al.  Characterization of Mouse Atp6i Gene, the Gene Promoter, and the Gene Expression , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  P. Delmas,et al.  The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* , 1998, The Journal of Biological Chemistry.

[12]  E. Jimi,et al.  Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time , 1998, Journal of cellular physiology.

[13]  A. Hollander,et al.  Molecular Interaction and Matrix Assembly , 1998, The Biochemical journal.

[14]  G. Wesolowski,et al.  Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. , 1997, Experimental cell research.

[15]  D. Veber,et al.  Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  E. Jimi,et al.  Phosphatidylinositol‐3 kinase is involved in ruffled border formation in osteoclasts , 1997, Journal of cellular physiology.

[17]  S. Pfeffer,et al.  Phosphatidylinositol 3-kinase is not required for recycling of mannose 6-phosphate receptors from late endosomes to the trans-Golgi network. , 1997, Molecular biology of the cell.

[18]  J. Mort,et al.  Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[19]  Jian Zhang,et al.  Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. , 1996, Biochemical and molecular medicine.

[20]  E. Vuorio,et al.  Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development , 1996, FEBS letters.

[21]  C. Debouck,et al.  Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*) , 1996, The Journal of Biological Chemistry.

[22]  J. H. Park,et al.  Sequence analysis of the 5'-flanking region of the gene encoding human N-acetylglucosaminyltransferase III. , 1996, Gene.

[23]  D. Brömme,et al.  Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts , 1996, The Journal of Biological Chemistry.

[24]  P. Yelick,et al.  Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  K. Chan,et al.  Progress in traditional Chinese medicine. , 1995, Trends in pharmacological sciences.

[26]  Sakae Tanaka,et al.  Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorption , 1995, FEBS letters.

[27]  G. Bilbe,et al.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. , 1995, Biochemical and biophysical research communications.

[28]  J. Clohisy,et al.  Prostanoid-induced expression of matrix metalloproteinase-1 messenger ribonucleic acid in rat osteosarcoma cells. , 1994, Endocrinology.

[29]  J. Palmer,et al.  Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. , 1994, Arthritis and rheumatism.

[30]  M. Kumegawa,et al.  Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. , 1994, The Journal of biological chemistry.

[31]  D. Kalu.  The ovariectomized rat model of postmenopausal bone loss. , 1991, Bone and mineral.

[32]  N. Udagawa,et al.  Role of colony‐stimulating factors in osteoclast development , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  M. Cecchini,et al.  Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. , 1990, Endocrinology.

[34]  D. B. Evans,et al.  The effects of recombinant human interleukin-1 beta on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. , 1990, Biochemical and biophysical research communications.

[35]  S. Yagel,et al.  Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. , 1989, Cancer research.

[36]  J. Phillipson,et al.  Ethnopharmacology and Western medicine. , 1989, Journal of ethnopharmacology.

[37]  Xiu Rj.  Microcirculation and traditional Chinese medicine. , 1988 .

[38]  J. Peter-Katalinic,et al.  Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. , 1988 .

[39]  J. Delaissé,et al.  In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. , 1984, Biochemical and biophysical research communications.

[40]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[41]  J. Delaisse,et al.  Inhibition of bone resorption in culture by inhibitors of thiol proteinases. , 1980, The Biochemical journal.

[42]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[43]  L. Raisz,et al.  Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. , 1969, Endocrinology.

[44]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[45]  J. You,et al.  The use of Chinese herbal medicine on experimental fracture healing. , 1997, The American journal of Chinese medicine.

[46]  K. C. Ma,et al.  Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. , 1996, The American journal of Chinese medicine.

[47]  A. Chambers,et al.  Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras‐transformed NIH 3T3 cells , 1992, Molecular carcinogenesis.

[48]  M. Passeri,et al.  Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis , 1992 .

[49]  H. Genant,et al.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. , 1987, Annals of internal medicine.